|
|
News Breaks | | | | September 7, 2012 | | 08:25 EDT |  | ARRY, ARRY, SCLN, SCLN, EXEL, EXEL, BMRN, BMRN, SCMP, SCMP, VVUS, VVUS, ZIOP, ZIOP, TSRX, TSRX, OREX, OREX, GTXI, GTXI, AGEN, AGEN | Biocentury & Thomson Reuters to host a conference
Biocentury and Thomson Reuter's Newsmakers in the Biotech Industry is being held in New York on September 7 with webcasted company presentations to begin at 8:30 am. Webcast Link | |
|
News For ARRY;GTXI;OREX;TSRX;ZIOP;VVUS;SCMP;BMRN;EXEL;SCLN;AGEN From The Last 14 Days Check below for free stories on ARRY;GTXI;OREX;TSRX;ZIOP;VVUS;SCMP;BMRN;EXEL;SCLN;AGEN the last two weeks. |
|
|
| May 17, 2013 | | 10:36 EDT | | SCMP | Leerink's major/specialty pharma analyst holds analyst/Industry conference call
 Subscribe for More Information | | | May 16, 2013 | | 16:04 EDT |  | SCLN | SciClone, Zensun enter licensing agreement for Neucardin
Subscribe for More Information | | | 16:02 EDT |  | SCLN | SciClone sees Q1 EPS 7c, two estimates 9c
Subscribe for More Information | | | 12:24 EDT |  | BMRN | On The Fly: Midday Wrap
The S&P 500 was virtually unchanged at midday following a deluge of domestic economic data this morning. The S&P began the session in negative territory, but only moderately lower, after investors received a host of data prior to the open, including reports on jobless claims, consumer prices, and housing starts. ECONOMIC EVENTS: In the U.S., initial jobless claims rose 32K to 360K last week, compared to expectations for them to remain relatively stable at 330K. The consumer price index dropped a larger than forecast 0.4% in April, though the "core" CPI rate rose 0.1%, as expected. Housing starts were down 16.5% in April from the prior month, versus an expected decrease of 6.4%, though building permits jumped 14.3% from the prior month, beating an expected increase of 3.8%. The Philadelphia Fed General Business Conditions Index for May came in at -5.2, versus expectations for a +2.2 reading. COMPANY NEWS: Earnings reports from two Dow members, Wal-Mart (WMT) and Cisco (CSCO), sent their shares in opposite directions. Cisco shares advanced 12% to lead the blue chip index after the company's results beat expectations on the top and bottom lines and prompted price target increases at several analyst firms. Wal-Mart, in contrast, lagged all Dow names, sliding 2% after its earnings for the just ended quarter and its view of the current quarter missed the consensus forecast... After the closing bell, Tesla Motors (TSLA) said it intends to raise about $830M by offering 2.7M common shares and $450M in convertible senior notes. CEO Elon Musk will buy $100M worth of the stock and debt, the company said, and its recently high-flying shares rose another 6%. MAJOR MOVERS: Among the notable gainers rising following Cisco's better than expected results and commentary were Ciena (CIEN), which rose 8%, and Cavium (CAVM), which advanced 4%. Also higher were shares of NetApp (NTAP), which gained over 6% after Bloomberg said activist investor Elliott Management has taken a stake in the company and is pushing its board to explore ways to boost shareholder value. Among the noteworthy losers were Oncothyreon (ONTY), which fell 20%, and Biomarin (BMRN), down 5%, after both pharmaceutical companies, among a number of others, published data to be presented at ASCO, an annual meeting of oncologists. Also lower was AMD (AMD), which declined 14% following a downgrade to Sell at Goldman Sachs. INDICES: Near noon, the Dow was up 12.47, or 0.08%, to 15,288.16; the Nasdaq was up 8.74, or 0.25%, to 3,480.36; and the S&P 500 was nearly flat at 1,658.80. | | | 11:50 EDT | | BMRN | Celgene, Gilead lower after new data published at ASCO
Subscribe for More Information | | | 09:03 EDT |  | BMRN | BioMarin volatility low, shares near record high into ACSO
Subscribe for More Information | | | 08:33 EDT |  | BMRN | BioMarin abstract showed impressive anti-tumor activity, says Leerink
Subscribe for More Information | | | May 15, 2013 | | 09:51 EDT | | ARRY | Array BioPharma management to meet with Leerink
Meeting to be held in San Francisco on May 17 hosted by Leerink. | | | May 14, 2013 | | 10:01 EDT |  | VVUS | On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AVG Technologies (AVG) downgraded to Neutral from Buy at Goldman... Cigna (CI) downgraded to Hold from Buy at Jefferies... Cree (CREE) downgraded to Neutral from Buy at Sterne Agee... Melco Crown (MPEL) downgraded to Neutral from Buy at UBS... SolarCity (SCTY) downgraded to Neutral from Buy at Roth Capital... KB Home (KBH) downgraded to Market Perform from Outperform at Raymond James... Ryland Group (RYL) downgraded to Underperform from Market Perform at Raymond James... Alere (ALR) downgraded to Hold from Buy at Craig-Hallum... Evolution Petroleum (EPM) downgraded to Hold from Buy at MLV Equity... Oil States (OIS) downgraded to Hold from Buy at BB&T... VIVUS (VVUS) downgraded to Neutral from Buy at Lazard Capital. | | | 07:33 EDT | | VVUS | VIVUS downgraded to Neutral from Buy at Lazard Capital
Subscribe for More Information | | | | 07:18 EDT | | EXEL | BofA/Merrill to host a conference
2013 Health Care Conference is being held in Las Vegas on May 14-16. | | | May 13, 2013 | | 15:31 EDT | | SCMP | Sucampo to hold a pharmaceutical update meeting
Pharmaceutical update to discuss the recent opioid-inducted constipation (OIC) indication approval for Sucampo's Amitiza is being held in Orlando, Florida on May 20 at 9 am. Webcast Link | | | 08:18 EDT | | TSRX | Trius Therapeutics annoucnes notice of patent applications
Subscribe for More Information | | | 07:41 EDT | | VVUS | VIVUS mails letter to stockholders providing business update
Subscribe for More Information | | | 07:39 EDT | | BMRN | BioMarin price target raised to $75 from $59 at Deutsche Bank
Deutsche Bank raised its price target for BioMarin citing increased value for the company's parp inhibitor. The firm keeps a Buy rating the stock. | | | May 10, 2013 | | 10:00 EDT |  | TSRX | On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 3D Systems (DDD) initiated with a Buy at Janney Capital... Actavis (ACT) initiated with an Outperform at BMO Capital... Allergan (AGN) initiated with an Outperform at BMO Capital... Emeritus (ESC) initiated with an Outperform at Wells Fargo... Ensign Group (ENSG) initiated with a Market Perform at Wells Fargo... Forest Labs (FRX) initiated with an Underperform at BMO Capital... J2 Global (JCOM) initiated with an Outperform at Wedbush... Mylan (MYL) initiated with an Underperform at BMO Capital... Splunk (SPLK) initiated with a Market Perform at FBR Capital... Teva (TEVA) initiated with an Outperform at BMO Capital... Workday (WDAY) initiated with an Outperform at Oppenheimer... Nuance (NUAN) initiated with an Outperform at Wedbush... Demandware (DWRE) initiated with an Outperform at Wedbush... Synchronoss (SNCR) initiated with an Outperform at Wedbush... Trius Therapeutics (TSRX) initiated with a Buy at Guggenheim... Proto Labs (PRLB) initiated with a Buy at Janney Capital... Stratasys (SSYS) initiated with a Buy at Janney Capital. | | | 07:25 EDT | | TSRX | Trius Therapeutics initiated with a Buy at Guggenheim
Subscribe for More Information | | | May 9, 2013 | | 07:32 EDT | | EXEL | Wells Fargo to host a conference
Subscribe for More Information | | | May 8, 2013 | | 16:11 EDT | | OREX | Orexigen reports Q1 EPS (21c), consensus (34c)
Reports Q1 revenue $857,000, consensus $890,000. | | | 07:35 EDT | | VVUS | VIVUS reports Q1 EPS (53c), consensus (51c)
Reports Q1 revenue $4.11M, consensus $5.22M. | | |
|
|
|
|
|
|
